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Presentation and Symptom Predictors of
Coronary Heart Disease in Patients With
and Without Diabetes
MARJORIE FUNK, PHD, RN, FAAN,* JANICE B. NAUM, MSN, APRN, CEN,†
KERRY A. MILNER, DNSC, RN,* AND DEBORAH CHYUN, PHD, RN*
The aims of this prospective, observational study were to compare: (1)
symptom presentation of coronary heart disease (CHD) between patients
with and without diabetes and (2) symptom predictors of CHD in patients
with and without diabetes. We directly observed 528 patients with symptoms suggestive of CHD as they presented to the ED of a 900-bed cardiac
referral center in the northeastern United States. There were no significant differences in symptom presentation of CHD between patients with
and without diabetes, although patients with diabetes were slightly more
likely to present with shortness of breath (P ⴝ .056). Patients with
diabetes reported their symptoms to be more severe compared with
those without diabetes (P ⴝ .036). Neck/throat pain and arm/shoulder
pain were of borderline significance in predicting CHD in patients with
diabetes (P ⴝ .059 and P ⴝ .052, respectively). Classic chest symptoms
and diaphoresis were independent predictors of CHD in patients without
diabetes (P ⴝ .002 and P ⴝ .049, respectively). The perceived severity of
symptoms was not predictive of CHD in patients with or without diabetes. Symptoms thought to be diagnostic of CHD are not helpful in patients with diabetes. Future research should focus on identifying more
useful predictors of CHD in patients with diabetes. (Am J Emerg Med
2001;19:482-487. Copyright © 2001 by W.B. Saunders Company)

According to the American Heart Association, coronary
heart disease (CHD) is the single largest killer of Americans. In 1998 alone, 459,841 deaths, or 1 in every 5 deaths
in the United States, were attributed to CHD. This year, it is
estimated that 1.1 million Americans will have a new or
recurrent myocardial infarction (MI) and over 40% of them
will die.1
It is well-established that diabetes mellitus is a strong risk
factor for CHD and that CHD represents the most common
cause of death for patients with diabetes. In fact, two-thirds
of people with diabetes die of some form of heart or blood
vessel disease.1 In patients with MI, diabetes is an important
prognostic factor for development of heart failure, recurrent
MI, and long-term mortality.2-7
CHD, however, is often silent in individuals with diabetes.8-12 It has been shown that one-quarter of the individuals
with diabetes had electrocardiogram (ECG) evidence of
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prior unrecognized MI. Half of these individuals had no
symptoms, whereas half had atypical symptoms.8 In the
National Registry of Myocardial Infarction-2 (NRMI-2),
diabetes was independently associated with atypical presentation.12
The occurrence of asymptomatic ischemia or presentation
with atypical symptoms makes diagnosing CHD difficult
and may result in a delay in initiating treatment in patients
with diabetes.13 Therefore, when patients present to the
emergency department (ED) with diabetes, there should be
a higher index of suspicion for CHD than for patients
without diabetes.
Triage in the ED is important in the early identification of
patients with potential cardiac problems. The assessment of
symptoms is critical to appropriate triage decisions. Increased knowledge of how patients with diabetes present
with CHD should enable expeditious and accurate identification of cardiac problems. This should lead to early intervention, as with thrombolytic therapy or primary angioplasty, that should limit infarct size, improve outcomes, and
reduce mortality. In fact, it has been found that patients with
diabetes receive thrombolytics less frequently than patients
without diabetes.14,15 Some have suggested that this is because of delayed recognition of symptoms as cardiac in
origin by the patient or by the clinician.15
In this study we sought to answer 2 research questions:
1. Is there a difference in symptom presentation of CHD
between patients with and without diabetes?
2. Is there a difference in symptom predictors of CHD
between patients with and without diabetes?
We hypothesized that: (1) patients with diabetes will be
more likely to present with atypical symptoms compared
with patients without diabetes; (2) typical symptoms will be
predictive of CHD in both patients with diabetes and patients without diabetes; and (3) atypical symptoms will be
predictive of CHD in patients with diabetes, but not in
patients without diabetes.
METHODS
Setting and Sample
We did a secondary analysis of data we collected for a larger
prospective study in which we examined various aspects of symptom presentation of CHD.16-18 We observed patients with symptoms suggestive of CHD as they presented to the ED of a 900-bed
cardiac referral center in the northeastern United States. Patients
were observed if they were ⱖ45 years of age and reported at least
one symptom suggestive of CHD (Table 1). Additionally, patients
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Presenting Symptoms Suggestive of Coronary Heart Disease
Typical Symptoms
Substernal chest pain (not related to trauma)
Left-sided chest pain (not related to trauma)
Chest pressure
Chest heaviness
Tightness or squeezing in chest
Neck or throat pain or discomfort (not related to trauma)
Jaw pain or discomfort (not related to toothache or trauma)
Shoulder pain or discomfort (not related to degenerative joint disease or trauma)
Arm pain or discomfort (not related to bursitis or trauma)
Diaphoresis
Shortness of breath (not related to asthma, pulmonary infection, pre-existing pulmonary problem, or renal failure)
Atypical Symptoms
Chest pain in other location
Fullness in chest
Stabbing in chest
Numbness, tingling, or pricking in chest
Burning in chest
Epigastric/indigestion-like/gas-like pain or discomfort (not related to gastrointestinal problem)
Nausea or vomiting (not related to gastrointestinal problem)
Upper extremity numbness or tingling (not related to stroke or carpel tunnel problem)
Midback (between shoulder blades) pain (not related to degenerative joint disease or trauma)
Pain/discomfort with deep breath (not related to asthma, pulmonary infection, or pre-existing pulmonary problem)
Cough (not related to asthma, pulmonary infection, or pre-existing pulmonary problem)
Dizziness, lightheadedness (not related to stroke, neurologic problem, or hypertension)
Syncope (not related to stroke, neurologic problem, or hypertension)
Fatigue or weakness (not related to stroke, neurologic problem, or hypertension)
Palpitations (new onset, no history of arrhythmias)

18 to 44 years were asked to participate if they had diabetes or at
least 2 cardiac risk factors (history of CHD, systemic hypertension,
hypercholesteremia, smoking, obesity, family history of premature
CHD, and postmenopausal state), and at least one symptom suggestive of CHD. We included these additional criteria for younger
patients to exclude patients at very low risk for CHD. A total of
536 patients met study criteria and were approached for participation. Of these, 531 patients agreed to participate (⬍1% refusal
rate). Information on diabetes status was missing on 3 patients,
resulting in a final sample size of 528.

criteria. CHD was defined as either acute ischemia or acute MI.
Acute ischemia was determined by ECG evidence of ST-segment
depression, ST-segment elevation, or T-wave inversion or T-wave
abnormalities different from the last ECG in at least 2 consecutive
leads and lack of cardiac enzyme elevation. Elevated cardiac
enzymes (CK-MB ⬎5% of total CK in at least one set) indicated
acute MI. Interrater agreement checks were done bimonthly during
the 2 years of data collection and were always above 95%.

Procedure

Data were analyzed using SAS Version 8 statistical software
(SAS, Cary, NC). For both research questions, only symptoms that
were reported by ⬎5% of the sample were included in the analyses. Because some symptoms are clinically similar and to ensure
adequate numbers for analyses, we combined some symptoms into
a single variable. Typical symptoms included classic chest symptoms as a single variable (pain, pressure, heaviness, tightness, or
squeezing in the center or left chest), neck or throat pain, jaw pain,
arm or shoulder pain, diaphoresis, or shortness of breath. Atypical
symptoms included atypical chest symptoms as a single variable
(fullness, stabbing, numbness, or burning in the chest or pain in the
right chest), epigastric discomfort, nausea or vomiting, upper extremity numbness or tingling, midback pain, pain with deep breath,
cough, dizziness or syncope, fatigue or weakness, and palpitations.
To address research question 1, we used chi-square analysis to
examine differences in symptom presentation of CHD between
patients with and without diabetes (n ⫽ 215 patients with CHD).
We performed a t-test to compare the mean rating of severity of
symptoms between patients with and without diabetes. We then
used multiple regression, with an alpha level of .20 for entering
and staying in the model, to control for factors that could have an
impact on perceived severity of symptoms. These included history
of heart failure, age, gender, prior diagnosis of CHD, psychiatric
history, and smoking.
To address research question 2, we did separate analyses for the
subgroups of patients with (n ⫽ 142) and without (n ⫽ 386)

This study was approved by the appropriate institutional review
boards. Between September 1995 and August 1997 during shifts of
2 to 5 hours across all 24 hours and all 7 days, nurse data collectors
unobtrusively observed all patients meeting study criteria as they
presented to the ED. The data collector approached the patient for
oral consent after the ED staff completed the initial assessment of
the patient and caregiving activities allowed. In the event that
patients were too sick to provide oral consent in the ED, patients
were approached when they were considered stable and were
within 24 hours of hospital admission. No patient died before
obtaining consent.
Data on presenting symptoms were obtained by observing the
patient-physician or patient-nurse interview, and symptoms were
documented verbatim. Data on baseline characteristics (demographics, preexisting health conditions, and cardiac risk factors)
were gathered from the patient and the medical record. Data on
severity of symptoms were obtained by asking the patient to
identify the number on a scale of 0 to 10 for the worst physical
discomfort they experienced on that day, where 0 was none at all
and 10 was the worst the patient could imagine. The presence of
diabetes mellitus was determined by asking the patient or family,
or from the medical record, and it was coded as either present or
absent. We did not have information on the type of diabetes (type
1 or type 2). CHD was determined by standard ECG and enzyme

Statistical Analyses
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diabetes. Initially, we used chi-square analysis to determine symptoms associated with CHD. Then to determine independent symptom predictors of CHD in patients with and without diabetes, we
performed stepwise logistic regression analysis in each group. We
entered all typical and atypical symptoms reported by ⬎5% of the
sample and forced in age and gender as control factors. We used
an alpha level of .20 for entering and staying in the model and
confirmed our results by forward selection and backward elimination modeling. We used t-test analyses to compare the mean rating
of severity of symptoms between patients with and without CHD
in the group of patients with diabetes and in the group without
diabetes.

RESULTS
Of a total sample of 528 patients, 215 were ultimately
diagnosed with CHD for their ED visit, 142 had diabetes,
and 66 had CHD and diabetes.
Symptom Presentation of CHD in Patients With and
Without Diabetes
To address our first research question regarding differences in symptom presentation of CHD between patients
with and without diabetes, we examined data from the 215
patients in the sample who were diagnosed with CHD (80
with acute MI and 135 with acute ischemia). A majority of
these patients with CHD were white (73.5%) and men
(58.6%). Ages ranged from 30 to 96, with a mean age of
65.9 ⫾ 14.8 years. We compared presenting symptoms in
the 66 with diabetes with presenting symptoms in the 149
who did not have diabetes.
As shown in Table 2, there were no statistically significant differences in symptom presentation between patients
TABLE 2. Differences in Symptom Presentation of Coronary
Heart Disease Between Patients With and Without Diabetes
by Chi-Square Analysis (N ⫽ 215)

Symptom
Typical Symptoms
Shortness of breath
Neck/throat pain
Diaphoresis
Classic chest symptoms
(pain, pressure,
heaviness, tightness,
or squeezing in center
or left chest)
Jaw pain
Arm/shoulder pain
Atypical Symptoms
Atypical chest symptoms
(fullness, stabbing,
numbness, or burning
in chest or pain in right
chest)
Nausea/vomiting
Dizziness/syncope
Fatigue/weakness
Palpitations
Epigastric discomfort
Midback pain

with diabetes and patients who did not have diabetes. Although the differences in the occurrence of shortness of
breath did not reach statistical significance, there was a
notable trend. Of the patients with diabetes, 51.5% experienced shortness of breath, in contrast to only 37.6% of those
without diabetes (P ⫽ .056). To determine if chest symptoms as a whole occurred more often in patients without
diabetes, we combined all classic chest symptoms (pain,
pressure, heaviness, tightness, or squeezing in the center or
left chest) into one variable. Although slightly more patients
without diabetes presented with classic chest symptoms
(71.1%) compared with patients with diabetes (68.2%), this
difference was not statistically significant (P ⫽ .662). Likewise, we also combined all atypical chest symptoms (fullness, stabbing, numbness, or burning in the chest or pain in
the right chest) into one variable. More patients without
diabetes presented with these atypical chest symptoms
(12.1%) compared with patients without diabetes (7.6%),
but this difference was not statistically significant (P ⫽
.324).
Using the 0 to 10 scale, patients with diabetes (mean ⫽
7.51 ⫾ 2.20) rated their symptoms as significantly more
severe than did those without diabetes (mean ⫽ 6.68 ⫾
2.58; P ⫽ .042). The relationship between diabetes and
severity of symptoms remained significant (P ⫽ .036) even
when using multiple regression to control for factors that
could have an impact on perceived severity of symptoms. It
is important to note, however, that only 173 of the 215
patients with CHD (80.5%) were able to quantify the severity of their symptoms using the 0 to 10 scale. We found
that older patients were less likely to be able to quantify the
severity of their symptoms. The mean age of those unable to
rate symptoms was 73.4 ⫾ 15.2 years, whereas the mean
age of those who did rate their symptoms was 64.1 ⫾ 14.2
(P ⫽ .0002).
Symptom Predictors of CHD in Patients With and
Without Diabetes

Diabetes
(n ⫽ 66)
N (%)

No
Diabetes
(n ⫽ 149)
N (%)

P

34 (51.5%)
9 (13.6%)
14 (21.2%)

56 (37.6%)
11 (7.4%)
40 (26.9%)

.056
.145
.380

45 (68.2%)
5 (7.6%)
21 (31.9%)

106 (71.1%)
8 (5.4%)
46 (30.9%)

.662
.752
.890

5 (7.6%)
17 (25.8%)
11 (16.7%)
10 (15.2%)
5 (7.6%)
10 (15.2%)
4 (6.1%)

18 (12.1%)
30 (20.1%)
31 (20.8%)
18 (12.1%)
8 (5.4%)
24 (16.1%)
10 (6.7%)

.324
.357
.480
.537
.752
.859
.999

To address our second research question regarding which
symptoms are predictive of CHD in patients with and without diabetes, we examined data first from the subgroup with
diabetes (n ⫽ 142) and then from the subgroup without
diabetes (n ⫽ 386).
Patients With Diabetes
Of the 142 patients with diabetes, 70.4% were white and
48.6% were men. Ages ranged from 32 to 93, with a mean
age of 65.3 ⫾ 13.7 years. We compared the 66 patients who
were diagnosed with CHD with the 76 who were not diagnosed with CHD.
As shown in Table 3, neck/throat pain and arm/shoulder
pain were significant (P ⬍ .05) bivariate predictors of CHD in
patients with diabetes. In these patients, 82% of those with
neck or throat pain were diagnosed with CHD, in contrast to
44% of patients without this symptom (P ⫽ .014). In addition,
64% of patients with arm or shoulder pain were diagnosed with
CHD, compared with 41% of patients without this symptom (P
⫽ .024). No other symptoms were significantly related to the
diagnosis of CHD in patients with diabetes.
To identify the most important symptom predictors in the
presence of many typical and atypical presenting symptoms,
we entered all symptoms into a logistic regression analysis,
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TABLE 3. Bivariate Symptom Predictors of Coronary Heart Disease in Patients With and Without Diabetes
Patients With Diabetes
(N ⫽ 142)
Symptom
Typical Symptoms
Neck/throat pain
Arm/shoulder pain
Classic chest symptoms (pain, pressure,
heaviness, tightness, or squeezing in
center or left chest)
Diaphoresis
Jaw pain
Shortness of breath
Atypical Symptoms
Dizziness/syncope
Epigastric discomfort
Fatigue/weakness
Palpitations
Nausea/vomiting
Atypical chest symptoms (fullness,
stabbing, numbness, or burning in chest
or pain in right chest)
Midback pain

Symptom
Present

Symptom
Absent

P

Symptom
Present

Symptom
Absent

P

82%
64%

44%
41%

.014
.024

36%
40%

39%
38%

.710
.648

51%
54%
42%
48%

39%
45%
47%
45%

.155
.405
.727
.736

43%
47%
50%
40%

31%
36%
38%
38%

.016
.087
.339
.610

39%
56%
40%
63%
47%

48%
45%
48%
46%
46%

.394
.409
.474
.568
.918

32%
37%
38%
25%
40%

41%
39%
39%
40%
38%

.101
.761
.867
.100
.782

45%
44%

47%
47%

.944
.999

41%
37%

38%
39%

.738
.863

while controlling for age and gender. Both neck/throat pain
and arm/shoulder pain achieved borderline significance
in predicting CHD (P ⫽ .052 and P ⫽ .059, respectively; see
Table 4).
In patients with diabetes, the perceived severity of symptoms did not differ between those who were diagnosed with
CHD for their ED visit and those who were not (P ⫽ .504).
Again, it is important to note that only 113 of the 142
patients with diabetes (79.6%) were able to quantify the
severity of their symptoms using the 0 to 10 scale.
Patients Without Diabetes
Of the 386 patients without diabetes, 73.8% were white
and 54.7% were men. Ages ranged from 22 to 96, with a
mean age of 62.5 ⫾ 16.3 years. We compared the 149
patients who were diagnosed with CHD with the 237 who
were not diagnosed with CHD.
As shown in Table 3, the combined variable of classic
chest symptoms was the only significant (P ⬍ .05) bivariate
predictor of CHD in patients without diabetes. In patients
TABLE 4.
Analysis

Patients Without Diabetes
(N ⫽ 386)

without diabetes, 43% of patients presenting with classic
chest symptoms were diagnosed with CHD, as compared
with 31% of patients who did not have classic chest symptoms (P ⫽ .016).
In this group of patients without diabetes, we entered all
symptoms into a logistic regression analysis, while controlling for age and gender, to determine the most important
symptom predictors of CHD in the presence of many typical
and atypical presenting symptoms. After taking these other
factors into account, classic chest symptoms was found to
be a significant predictor of CHD (P ⫽ .002; see Table 4).
The odds ratio indicates that patients presenting with classic
chest symptoms are twice as likely to be diagnosed with
CHD, compared with patients without these symptoms (adjusted odds ratio ⫽ 2.10; 95% confidence interval ⫽ 1.31 ⫺
3.37). Diaphoresis was also found to be a significant predictor of CHD (adjusted odds ratio ⫽ 1.68; 95% confidence
interval ⫽ 1.00 ⫺ 2.81; P ⫽ .049).
As in patients with diabetes, in patients without diabetes
the perceived severity of symptoms did not differ between

Independent Symptom Predictors of Coronary Heart Disease in Patients With and Without Diabetes by Logistic Regression

Symptom
Patients with diabetes
Arm/shoulder pain
Neck/throat pain
Patients without diabetes
Classic chest symptoms (pain, pressure, heaviness, tightness,
squeezing in center or left chest)
Diaphoresis
Atypical chest symptoms (fullness, burning, stabbing, or
numbness in chest or pain in right chest)
* Controlled for age and gender

Adjusted
Odds Ratio*

95% Conﬁdence
Interval

P

2.39
4.82

0.99-5.72
0.94-24.64

.052
.059

2.10
1.68

1.31-3.37
1.00-2.81

.002
.049

1.68

0.85-3.35

.138
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those who were diagnosed with CHD for their ED visit and
those who were not (P ⫽ .559). Again, it is important to
note that only 303 of the 386 patients with CHD (78.5%)
were able to quantify the severity of their symptoms using
the 0 to 10 scale.
DISCUSSION
The results of our study suggest that symptoms of CHD
are similar for patients with and without diabetes, however
those with diabetes reported their symptoms to be more
severe. Neck/throat pain and arm/shoulder pain were of
borderline significance in predicting CHD in patients with
diabetes. Classic chest symptoms and diaphoresis were independent predictors of CHD in patients without diabetes.
The perceived severity of symptoms was not predictive of
CHD in patients with or without diabetes. Thus, our data do
not support our hypotheses that: (1) patients with diabetes
will be more likely to present with atypical symptoms
compared with patients without diabetes; (2) typical symptoms will be predictive of CHD in both patients with diabetes and patients without diabetes; and (3) atypical symptoms will be predictive of CHD in patients with diabetes,
but not in patients without diabetes.
Symptom Presentation of CHD in Patients With and
Without Diabetes
Previous research suggests that individuals with diabetes
are more likely to have silent ischemia and are more likely
to experience a silent MI compared with individuals without
diabetes.8-12 In the setting of acute MI, some researchers
have found that people with diabetes are less likely to
experience ischemic chest pain and have suggested that this
may be related to the presence of cardiovascular autonomic
neuropathy.9,12,19 Others, however, have shown that chest
pain was seen with equal frequency in people with and
without diabetes20 or only slightly less often in individuals
with diabetes.21,22
Because inclusion criteria for our study required patients
to have symptoms suggestive of CHD, we cannot comment
on the incidence of silent ischemia or silent MI. Regardless
of diabetes status, patients in our sample were equally likely
to present with chest symptoms. When we combined all
classic chest symptoms together, there was no significant
difference in the occurrence of classic chest symptoms
between those with and without diabetes (68.2% v 71.1%,
respectively; P ⫽ .662). In a study of 7,157 patients presenting to the ED, Herlitz et al22 found that chest pain
occurred slightly less often in patients with diabetes than in
those without diabetes (90% v 93%, respectively; P ⬍ .05).
Our smaller sample size (n ⫽ 215 with CHD), and resulting
lower statistical power, may account for the lack of observed statistical difference in the occurrence of classic
chest symptoms in patients with and without diabetes in our
study.
Findings from our study also do not indicate that patients
with diabetes are more likely to present with atypical symptoms. There was no significant difference in the occurrence
of atypical chest symptoms between those with and without
diabetes (P ⫽ .324). Although more patients with diabetes
presented with shortness of breath, the difference did not
quite reach statistical significance (P ⫽ .056). A potentially

higher incidence of shortness of breath in patients with
diabetes may be related to a higher incidence of heart failure
that is frequently found in individuals with diabetes on
presentation with acute ischemia.7,21,22 Herlitz et al22 also
found pulmonary and pleural symptoms more frequently in
patients with diabetes, however, the difference was not
statistically significant and prevalence was far less than in
the present investigation. In addition, Herlitz et al22 did not
assess other symptoms in as great detail as in the present
study.
In the present study, patients with diabetes rated the
severity of their symptoms higher than patients without
diabetes. This finding is contrary to the cardiovascular autonomic neuropathy hypothesis. In our sample, we did not
have any information on physiologic indicators of cardiovascular autonomic neuropathy, nor did we know about
degree of glycemic control or duration of diagnosis of
diabetes. This finding of increased severity of symptoms
could be reflective of more extensive cardiac disease and the
compounding effect of multiple system involvement in patients with diabetes, compared with patients without diabetes. In addition, we considered not only pain, but many
types of symptoms.
It is important to note, however, that not all patients with
CHD were able to quantify the severity of their symptoms
using the 0 to 10 scale. Therefore, we may not be able to
generalize our findings to the whole population of patients
with CHD. In particular, the increased perceived severity of
symptoms may not be true in older patients, many of whom
were unable to quantify the severity of their symptoms
using the 0 to 10 scale. Although our information on the
severity of symptoms is limited, it is the first time that this
has been examined in this population of patients. Further
investigation regarding differences in perception of severity
of symptoms between those with and without diabetes is
indicated.
Symptom Predictors of CHD in Patients With and
Without Diabetes
Logistic regression analysis revealed that neck/throat
pain and arm/shoulder pain were of borderline significance
in predicting CHD in patients with diabetes. Even when we
combined pain, pressure, heaviness, tightness, or squeezing
in the center or left chest into one variable, we found that
these classic chest symptoms were not predictive of CHD in
patients with diabetes. On the other hand, the presence of
classic chest symptoms and diaphoresis were independent
predictors of CHD in patients without diabetes.
No previous investigations have examined symptom predictors of CHD in patients with diabetes. Likewise, there is
little research-based knowledge of symptom predictors of
CHD in the general population, although the nomenclature
of “classic” and “typical” used in reference to certain symptoms indicates that we consider these symptoms to be predictive of CHD. Indeed, our results support the association
of classic chest symptoms and diaphoresis with CHD in
patients without diabetes.
Strengths and Limitations
There are several strengths and limitations that may influence the interpretation of our findings. Strengths include
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our prospective, observational design in which detailed data
on presenting symptoms were collected by direct observation in the ED. This approach minimizes recall bias on
reporting of symptoms and maximizes accuracy. The potential problem of health care professionals interpreting
patients’ symptoms and recording medical terms is avoided.
Second, we considered all types of typical and atypical
symptoms suggestive of CHD, not just chest pain. Lastly,
this is the first study to examine symptom predictors of
CHD among patients with and without diabetes.
Limitations include the relatively small number of patients with diabetes who were diagnosed with CHD. This
may have resulted in the lack of observed differences in
most of the symptoms between patients with and without
diabetes. Larger studies are needed to examine differences
in symptom presentation and to determine symptom predictors of CHD in patients with diabetes. Second, we did not
have data on the type of diabetes (type 1 or type 2), the
degree of glycemic control, or indicators of cardiovascular
autonomic neuropathy. Also, some patients with diabetes
may not have been diagnosed yet, and thus they were
included in the group without diabetes. In addition, sample
size limitations required that we collapse patients with acute
ischemia and MI into one group for the analyses, thus
precluding an analysis of presenting symptoms in patients
with acute MI.
CONCLUSIONS
With these strengths and limitations in mind, we can
conclude that there were more similarities than differences
in symptom presentation of CHD between patients with and
without diabetes, although patients with diabetes reported
their symptoms to be more severe compared with those
without diabetes. Neck/throat pain and arm/shoulder pain
were of borderline significance in predicting CHD in patients with diabetes. Classic chest symptoms and diaphoresis were independent predictors of CHD in patients without
diabetes. Clinicians need to be aware that patients with
diabetes can present with a wide variety of symptoms and
that symptoms thought to be diagnostic of CHD are not
helpful in patients with diabetes. Future research should
focus on identifying more useful predictors of CHD in
patients with diabetes.
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